Advancis Loses Partnership With Brits GlaxoSmithKline's decision not to partner up is a setback to Advancis' plans to redevelop some commonly prescribed oral antibiotics to perform more efficiently. &lt;FONT face="verdana,MS Sans Serif,arial,helvetica" size="-2"\ color="#666666"&gt;&lt;B&gt;-The Washington Post&lt;/B&gt;&lt;/FONT&gt;